Ansell Limited

ANSLF

Medical - Instruments & Supplies · Healthcare

Price

$21.64

+0.00 (+0.00%)

Market Cap

$3.05B

Exchange

Other OTC

Winston Score

Winston is curious

Mixed quality — meaningful strengths and weaknesses.

Data as of Aug 23, 2026 · filings through Dec 31, 2025

How the score breaks down

Quality

Good

Growth

Good

Cash Flow

Strong

Stability

Strong

Valuation

Good

Dividends

Good

Track this stock — start free trial

Share count rising — dilution

+12.3% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 130.1M (2021) → 146.1M (2025)

Winston Score History

The full picture

Ansell Limited makes protective gloves, clothing, and other safety gear used by workers and medical professionals around the world. Its products include surgical gloves, exam gloves, and industrial protective suits sold to hospitals, factories, chemical plants, and food processing facilities. The company is one of the largest manufacturers of protective solutions globally, with well-known brands like GAMMEX and HyFlex.

Ansell earns money by selling its products directly to businesses and through distributors, operating across two main segments: Health & Protection (medical gloves and apparel) and Industrial (workplace safety gear). It is headquartered in Australia but generates most of its revenue from North America, Europe, and Asia. Ansell's competitive edge comes from its broad product range, strong brand recognition, and deep customer relationships in regulated industries. A key risk is that raw material costs — especially latex and synthetic rubber — can squeeze profit margins when commodity prices rise.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+9.5% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+80.0% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$21M/ year

1.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

0.0%ownership

Relatively low insider ownership

Cash Position

Cash flow positive

$258M cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Ansell Limited is growing revenue at 10% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

40.8%

Healthy — 40.8% gross margin

Profit after running costs

Operating Margin

13.6%

Healthy — 13.6% operating margin

Return on the money invested

ROCE

8.3%

Below par — 8.3% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

+15.4%

Fast-growing sales (+15.4% YoY)

Profit growth

EPS YoY

+23.1%

Earnings growing fast (+23.1% YoY)

Healthy double-digit earnings growth — what compounders look like.

How steady the profit is

EPS Consistency

3/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

179%

Turns 179% of profit into real cash

Spare cash per sale

FCF Margin

8.5%

Modest free cash flow (8.5%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

0.42

Conservative — low debt load (0.42)

Covers its interest

Interest Cover

5.01x

Adequate interest coverage (5.0x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

22.5x

Growth-priced — P/E 22.5

P/E above the market average. People are paying up for expected growth.

Cheaper or dearer next year

P/E vs Forward

+5.9

GROWING

Earnings expected to grow meaningfully — cheaper on forward P/E (22.5 → 16.6)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend

Dividend Yield

2.27%

Moderate income — 2.27% yield

Standard yield zone for stable dividend payers. A meaningful piece of total return.

Dividend record

Dividend Growth

+5.4%

Dividend growing modestly (5.4% YoY)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial